Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
about
Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics.An (R)-specific N-methyltransferase involved in human morphine biosynthesis.Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system.Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease.Racemic Salsolinol and its Enantiomers Act as Agonists of the μ-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase PathwayThe biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application.Salsolinol Damaged Neuroblastoma SH-SY5Y Cells Induce Proliferation of Human Monocyte THP-1 Cells Through the mTOR Pathway in a Co-culture System.PACAP protects against inflammatory-mediated toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway.PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease.Parkinson's disease: genetics and beyond.Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated.Catechol-O-methyltransferase: potential relationship to idiopathic hypertension.Analysis of drug-endogenous human metabolite similarities in terms of their maximum common substructures.Aromatic Amines Exert Contrasting Effects on the Anticoagulant Effect of Acetaldehyde upon APTT.Increased levels of monoamine-derived potential neurotoxins in fetal rat brain exposed to ethanol.Low Vs. High Alcohol: Central Benefits Vs. Detriments.Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease.Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.A simple iridicycle catalyst for efficient transfer hydrogenation of N-heterocycles in water.Synthesis of C3/C1-Substituted Tetrahydroisoquinolines.Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release.
P2860
Q33337387-9D84BC6E-BEB5-4657-9745-51C0B41F005FQ33984416-D6F030DC-371F-4DEB-9B45-E9E96B04C228Q34540434-65677AC9-0263-4B48-964D-EB0B28793037Q35159859-665F6035-DA00-4588-854A-84D150D565ABQ35252890-A3E8CDE0-2775-495D-B8CC-CD08598917EAQ36039402-7BB7B907-D8CE-450F-B2D5-EE57C57620D0Q36163354-8A6A7B7F-0894-48E0-BDDE-B38555EDBFABQ37597891-4F62E173-8E25-43C3-94C3-F4483B59956EQ37845675-26D4F604-87F6-43E3-BCEF-1B1C43EDA244Q38110453-D10CB900-F67C-435D-8D64-BAC259DF609FQ38899693-E3677D30-677A-48DC-A1E4-907D837B9743Q39003365-A3AFFA85-EE14-4B7E-9DBB-813EE963CED2Q39036997-40F5676B-316B-4B3C-A81A-4CB72F936096Q39159132-F183613C-7609-412A-BF97-E499B713664CQ39416222-2EA83249-D00D-4849-A8CD-AFA898932A87Q39609418-FC533C7B-2F5E-4529-9EA6-FBBFE42BF4D1Q41286555-DD8A2155-87EE-4C8E-B6C1-B1DFD7CEC35AQ41959283-D1E57617-A829-4BE7-B424-8DC39BA0873AQ43077613-816D18A3-90B0-4225-8037-52EF44183914Q44625406-5B063F2D-EAE5-4AA1-8938-82067AF87075Q47663680-AF4AA9B6-97BD-4091-AFE5-FB2517A13904Q47774778-A548C966-5716-498A-BBD9-7279FEDE12C5Q48004001-6FC19950-8622-4FBD-BA24-75D9A8463F9CQ50438582-8787FE14-9053-4623-A23B-12211DD76EA1Q50944497-45566CB8-0DED-482D-ABD3-037777E4F7D0Q55023810-7F74C506-BCBF-4646-AEDC-489591CED8DD
P2860
Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Dopamine-derived salsolinol de ...... and function in human brains.
@ast
Dopamine-derived salsolinol de ...... and function in human brains.
@en
Dopamine-derived salsolinol de ...... and function in human brains.
@nl
type
label
Dopamine-derived salsolinol de ...... and function in human brains.
@ast
Dopamine-derived salsolinol de ...... and function in human brains.
@en
Dopamine-derived salsolinol de ...... and function in human brains.
@nl
prefLabel
Dopamine-derived salsolinol de ...... and function in human brains.
@ast
Dopamine-derived salsolinol de ...... and function in human brains.
@en
Dopamine-derived salsolinol de ...... and function in human brains.
@nl
P2093
P1433
P1476
Dopamine-derived salsolinol de ...... and function in human brains.
@en
P2093
Georgy M Nagy
Makoto Naoi
Wakako Maruyama
P304
P356
10.1016/S0161-813X(03)00099-8
P577
2004-01-01T00:00:00Z